Protein Engineering vol. 16 no. 10 pp. 753-759, 2003
© 2003 Oxford University Press
Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment
1National Cancer Institute at Frederick, Frederick, MD 21702, USA and 2School of Animal and Microbial Sciences, The University of Reading, Whiteknights, PO Box 228, Reading RG6 6AJ, UK 3Present address: National Cancer Institute, Biometric Research Branch, Bethesda, MD 20892-8315, USA
4 To whom correspondence should be addressed. e-mail: rybak{at}ncifcrf.gov
A prerequisite for the enrichment of antibodies screened from phage display libraries is their stable expression on a phage during multiple selection rounds. Thus, if stringent panning procedures are employed, selection is simultaneously driven by antigen affinity, stability and solubility. To take advantage of robust pre-selected scaffolds of such molecules, we grafted single-chain Fv (scFv) antibodies, previously isolated from a human phage display library after multiple rounds of in vitro panning on tumor cells, with the specificity of the clinically established murine monoclonal anti-CD22 antibody RFB4. We show that a panel of grafted scFvs retained the specificity of the murine monoclonal antibody, bound to the target antigen with high affinity (6.4–9.6 nM), and exhibited exceptional biophysical stability with retention of 89–93% of the initial binding activity after 6 days of incubation in human serum at 37°C. Selection of stable human scaffolds with high sequence identity to both the human germline and the rodent frameworks required only a small number of murine residues to be retained within the human frameworks in order to maintain the structural integrity of the antigen binding site. We expect this approach may be applicable for the rapid generation of highly stable humanized antibodies with low immunogenic potential.
Received June 10, 2003; accepted August 27, 2003.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Menzel, T. Schirrmann, Z. Konthur, T. Jostock, and S. Dubel Human antibody RNase fusion protein targeting CD30+ lymphomas Blood, April 1, 2008; 111(7): 3830 - 3837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ho, R. J. Kreitman, M. Onda, and I. Pastan In Vitro Antibody Evolution Targeting Germline Hot Spots to Increase Activity of an Anti-CD22 Immunotoxin J. Biol. Chem., January 7, 2005; 280(1): 607 - 617. [Abstract] [Full Text] [PDF]
|
|